Belize vs Myanmar: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati
Belize
75.0%
in 2025
Myanmar
71.0%
in 2025
Belize rank
130th
Myanmar rank
133rd
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati over time
- Belize
- Myanmar
How they compare
Belize currently reports 75.0% against 71.0% in Myanmar, a difference of 4.0%.
That makes Belize's figure about 1.1 times Myanmar's.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Myanmar ahead.
Belize ranks 130th and Myanmar ranks 133rd of 194 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Belize | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 0.0% | 28.4% | 28.4% | Myanmar |
| 2020s | 19.0% | 64.8% | 45.8% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati, Belize or Myanmar?
- Belize, at 75.0% against 71.0% in Myanmar as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati between Belize and Myanmar?
- 4.0%, with Belize ahead.
- How many years of comparable data are there for Belize and Myanmar?
- 18 years are reported by both, from 2008 to 2025.
- How do Belize and Myanmar rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Belize ranks 130th and Myanmar ranks 133rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.